Canada· CA-DIN-02466376
ANTI-SHINE ANTHELIOS XL DRY TOUCH GEL-CREAM
A d02ba30 product containing avobenzone + octisalate + drometrizole trisiloxane + octocrylene, registered in Canada by LABORATOIRES LA ROCHE-POSAY CANADA.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- AVOBENZONE + OCTISALATE + DROMETRIZOLE TRISILOXANE + OCTOCRYLENE
- Manufacturer
- LABORATOIRES LA ROCHE-POSAY CANADA
- Country
- Canada (CA)
- ATC code
- D02BA30
- ATC class
- D02BA30
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D02BA30
D02ba30, as other registers publish it.
- Canada7 IN ONE CC TONE CORRECTINGPROCTER & GAMBLE INC
- CanadaABSOLUTELY AGELESS DAILY MOISTURIZERJOHNSON & JOHNSON INC
- CanadaADAPTASUN SEA AND TROPICS PROTECTIVE BODY LOTION SPF 30NAOS CANADA INC.
- CanadaAGE PERFECT ROSY TONE DAY CREAML' OREAL CANADA
- CanadaANEW PLATINUM DAY CREAMTHE AVON COMPANY CANADA LIMITED
- CanadaANEW ULTIMATE MULTI-PERFORMANCE DAY CREAM CRÈME DE JOUR BROAD SPECTRUM SPF25 À LARGE SPECTRE FPS 25THE AVON COMPANY CANADA LIMITED
- CanadaANTHELIOS AGE CORRECTLABORATOIRES LA ROCHE-POSAY CANADA
- CanadaANTHELIOS DERMO-KIDS 50+LABORATOIRES LA ROCHE-POSAY CANADA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eaafeaf3-e7d0-4170-8d97-57c6c2aba74b GET /v1/drugs/eaafeaf3-e7d0-4170-8d97-57c6c2aba74b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02466376",
"form": "CREAM",
"class": "Human",
"routes": [
"TOPICAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "D02BA30",
"schedule": [
"OTC"
],
"drug_code": "95472",
"strengths": [
"3 %",
"5 %",
"0.5 %",
"7 %",
"15 %"
],
"ahfs_class": null,
"substances": [
"AVOBENZONE",
"OCTISALATE",
"DROMETRIZOLE TRISILOXANE",
"OCTOCRYLENE",
"HOMOSALATE"
],
"product_categorization": null
}See everything about d02ba30.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.